The aims of this study were to develop a robust method for simultaneous quantification of carboxylesterases (CESs) 1 and 2 and to quantify those absolute protein levels in human liver tissue fractions. Unique peptide fragments of CES1 and CES2 in tryptically digested human liver microsomes (HLMs) and cytosol (HLC) were simultaneously quantified by liquid chromatography equipped with tandem mass spectrometry (LC-MS/MS) using corresponding stable isotope-labeled peptides as internal standards. Bovine serum albumin was used as a blank matrix for the calibration curve samples. Our procedure showed good digestion efficiency, sensitivity, linearity of calibration curve, and reproducibility. The protein levels of CES1 and 
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Introduction
Carboxylesterases (CESs, EC 3.1.1.1) are members of the esterase superfamily that hydrolyzes various ester-bearing molecules (Imai, 2006; Hosokawa et al., 2007; Ross and Crow, 2007; Hosokawa, 2008) . In humans, the majority of CESs belongs to the CES1 and CES2 gene families. Presently, two isoforms are available for both CES1 and CES2 in the Universal Protein Resource Knowledge Base (UniProtKB).
CESs are expressed in human liver with primary localization in the luminal side of the endoplasmic reticulum (ER), and are also found in lower quantities in the cytosolic fraction. Quantitative immunoblot analysis of four different pooled human liver microsomes (HLMs) showed protein levels of CES1 and CES2 to be 1070 and 23.0 pmol/mg, respectively (Godin et al., 2007; Ross and Crow, 2007) . However, the accuracy and precision of immunoblot analysis were not fully investigated in their reports. In addition, there seems to be a great amount of variability in the relative expression. Ross et al. found that expression levels varied by factors of 1.3 and 2.3 for CES1 and CES2, respectively, in 11 individual HLMs (Ross et al., 2006; Ross and Crow, 2007) , whereas Hosokawa et al. reported that the factor is actually closer to 10 for CES1 after studying 12 individual HLMs (Hosokawa et al., 1995) , and Xu et al. found the factor to be closer to 3 for CES2 after examining 13 individual HLMs (Xu et al., 2002) . These differences might be due to the origin of microsomes samples or the accuracy of the immunoblot-based quantification, as factors such as sample loading, blotting, and detection may affect the results.
Therefore, an alternative method that can quantify protein levels more accurately has been sought. Since 2005, MS-based protein quantification has been applied to several ADME-related proteins including CYPs (Alterman et al., 2005; Langenfeld et al., 2009; Seibert et al., 2009; Kawakami et al., 2011; Sakamoto et al., 2011; Williamson et al., 2011; Ohtsuki et al., 2012; Schaefer et al., 2012) , transporters (Kamiie et al., 2008; Li et al., 2008; Li et al., 2009; Li et al., 2010; Sakamoto et al., 2011; Zhang et al., 2011) , and UGTs (Fallon et al., 2008; Sakamoto et al., 2011; Harbourt et al., 2012; Ohtsuki et al., 2012) . To our knowledge, however, similar studies have not been done for CESs.
Here, we simultaneously quantified CES1 and CES2 in human liver tissue fractions by an original, highly sensitive, accurate and robust method using LC-MS/MS. Correlations between protein levels and hydrolysis activities for respective substrates (clopidogrel and oxybutynin for CES1; irinotecan for CES2) were investigated to assess the reliability of quantified protein levels. of supernatant was injected into the LC-MS/MS system mentioned above. LC was performed using a Synergi Fusion-RP 100A 50 × 2.00 mm, 2.5-micron column (Phenomenex, Torrance, CA, USA) at a flow rate of 0.4 mL/min. The HPLC mobile phases were solutions A and B (see above) with a gradient program of 5-30% B for 3 min, 30-100% B for 3.01 min, 100-100% B for 3.5 min, 100-5% B for 3.51 min, and 5% B for 6 min. The sample rack and column temperatures were maintained at 10°C
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and 45°C, respectively. Quantification was performed in positive MRM mode (Table   1 ). Data were processed using the Analyst 1.5.1 software package (AB SCIEX).
Measured peptide concentrations were converted to protein levels (pmol/mg protein).
This article has not been copyedited and formatted. The final version may differ from this version. (back-calculated values) were obtained by applying the peak area ratio (analyte peak to IS peak) to each nominal concentration, and the correlation coefficients (r) were determined. Reproducibility of our method from the tryptic digestion step to quantification step was investigated using pooled human liver tissue fractions. Pooled
HLMs and HLC were digested in six replicates and concentrations of CES1-and CES2-unique peptides were quantified by calibration curves in three different batches.
Mean, standard deviation (SD), and the coefficient of variation (CV) for each batch (intra-day reproducibility) as well as for overall experiments (inter-day reproducibility)
were determined.
Correlation Analysis. The protein levels of CES1 and CES2 were quantified in 16
individual HLMs. Linear regression analysis was performed using GraphPad Prism software ver. 5.03 (GraphPad Software, San Diego, CA, USA). Correlations between the protein levels of CES1 and CES2 and between protein levels and the respective hydrolysis activities were investigated. The hydrolysis rates of clopidogrel, oxybutynin, and irinotecan obtained in our previous report were used (Sato et al., 2012) .
This article has not been copyedited and formatted. The final version may differ from this version. to Arg199 and Glu366 to Lys374, respectively ( Fig. 1 ).
Digestion Efficiency in Human Liver Tissue Fractions. The results of the
Coomassie blue staining indicate that whole proteins were digested by trypsin in both
HLMs and HLC ( Fig. 2A ). In addition, the objective bands of CES1 and CES2 in the Western blotting analysis were detectable in the lanes of undigested HLMs and HLC even after dilution by a factor of 10, while no bands were detected in the lanes of digested HLMs and HLC (Fig. 2B ).
Development and Validation of a Simultaneous Quantification Method for CESs
in Human Liver Tissue Fractions. A method to simultaneously quantify the protein levels of CES1 and CES2 in HLMs and HLC was developed using unique peptides and corresponding AQUA ® peptides as reference standards and IS, respectively (Table 1) .
A high throughput gradient LC program with a run-time of 6 min was established by adopting a polar-embedded C18 analytical column with small particles (2.5 μ m) to achieve a high signal to noise ratio and good retention of peptides. After preliminary experiments, the lower limit of quantification (LLOQ) of the calibration curves was set to 500 and 50 ng/mL for CES1-and CES2-specific peptides, respectively, when using shown in Fig. 3 and 4, respectively. No interference peaks were observed in the chromatograms of the digested BSA samples for either analyte ( Fig. 3A and 4A ) based on the chromatograms of the LLOQs (Fig. 3B and 4B ). Both analyte peaks were confirmed in the retention times of the reference standards in the chromatograms of digested HLMs (Fig. 3C and 4C ) and HLC ( Fig. 3D and 4D ), whereas no analyte peaks were observed in the chromatograms of undigested HLMs ( Fig. 3E and 4E ) or HLC ( Fig. 3F and 4F ). Typical calibration curves are shown in Fig. 5 . The quantification range was set at 200-fold for both analytes. The relative errors (%) of calibration curve samples were ≤ 6.0% for both analytes ( Table 2) . Reproducibility of the process from tryptic digestion to quantification was investigated by repeating tryptic digestion of pooled HLMs and HLC in six replicates followed by LC-MS/MS analysis three times (Table 3 ). In HLMs, the overall averages of quantified concentrations of CES1-and CES2-specific peptides were 10400 and 420 ng/mL (equivalent to 363 and 22.2 pmol/mg), with CV values of 4.4% and 7.8%, respectively. In HLC, these were 1570 and 52.1 ng/mL (equivalent to 54.5 and 2.76 pmol/mg), with CV values of 5.6% and 18%, respectively. The concentrations of CES2-specific peptide in 7 of 18 replicates of digested HLC were slightly below the LLOQ and calculated by extrapolation.
Quantification of CES1 and CES2 in Individual HLMs. Protein levels of CES1 and CES2 were quantified in 16 individual HLMs (Table 4 ). The protein levels of CES1 ranged from 171 to 801 pmol/mg with an average of 402 pmol/mg. The protein levels of CES2 ranged from 16.3 to 57.2 pmol/mg with an average of 29.8 pmol/mg.
Inter-individual variability in the protein levels of CES1 and CES2 were 4.7-and 3.5-fold, respectively. The CES1 to CES2 level ratio substantially varied from 3.0 to This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. Two isoforms of CES1 (isoforms 1 and 2) are available in the UniProtKB with isoform 1 being the canonical sequence. The sequence of these isoforms are almost identical, differing in only one amino acid residue (Ala18). The sequence GNWGHLDQVAALR is common to both CES1 isoforms, however, as the function of these two isoforms was expected to be identical, the above sequence was assumed to be a specific fragment representing the function of CES1. For CES2, two isoforms (isoforms 1 and 2) are also available in the UniProtKB with isoform 1 being the canonical sequence. The sequence EASQAALQK is common to both CES2 isoforms, however, because the mRNA level of isoform 2 in the total CES2 transcript was very low (Schiel et al., 2007) , the above sequence was assumed to be a specific fragment representing the function of CES2. CESs are known as glycoproteins (Kroetz et al., 1993) , and therefore may complicate MS-based protein quantification due to post-transcriptional modifications like glycosylation. However, this concern does not apply to our study, as the above sequences do not possess any glycosylation sites.
Moreover, there are no cysteine residues that may also compromise the MS analysis.
This article has not been copyedited and formatted. The final version may differ from this version. (Fig. 2) . The chromatograms of the digested BSA samples and LLOQs indicate good selectivity for MRM analysis (Fig. 3A , 3B, 4A and 4B). Additionally, the chromatograms of the digested and undigested human liver tissue fractions indicate that the peaks observed in the digested fractions were generated by tryptic digestion (Fig. 3C-3F and 4C-4F).
Based on the r values and relative errors of calibration curve samples, we concluded that the linearity of the curves was good for both analytes ( Fig. 5 and Table 2 ). The CV values of the quantified peptide concentrations in digested human liver tissue fractions indicate that quantification is reproducible, although the CV values for CES2 in HLC were relatively high, due to the fact that concentrations of CES2-specific peptide in digested HLC were as low as the LLOQ (Table 3) . These results indicate that this method for the quantification of CESs in human liver tissue fractions was robust.
In pooled HLMs, CES1 level (363 pmol/mg) was low compared with the previously reported value measured by immunoblot (1070 pmol/mg), whereas CES2 level (22.2 pmol/mg) was comparable to the previously reported value (23.0 pmol/mg).
Although the precise reason for this discrepancy remains unknown, it might be due to a difference in reference standards. In the immunoblot analysis, recombinant human CES proteins purified from baculovirus expression systems were used as reference standards for calibration curves (Godin et al., 2007) . Some non-specific bands were This article has not been copyedited and formatted. The final version may differ from this version. observed in their immunoblots of purified CES1, which might indicate impurity in the standard protein of CES1, while no apparent non-specific band was shown in their immunoblots of purified CES2. In LC-MS/MS-based quantification, however, highly purified reference peptides (purity of ≥ 95%) were used as standards, which were able to provide highly reliable quantified values. Although the CES1 level quantified in the present study was lower than the reported value, the protein level of CES1 is considered much higher than that of CES2 in HLMs, as presented in the UniProtKB. In pooled HLC, the protein level of CES1 (54.5 pmol/mg) was markedly higher than that of CES2 (2.76 pmol/mg), and protein levels of CESs in HLCs were almost 10 times lower than those in HLMs. These results indicate that CESs are primarily expressed in the microsomal fraction, as presented in the UniProtKB.
Protein levels of CESs in individual samples were quantified only in HLM, as CES levels in HLMs were confirmed to be markedly higher than those in HLC and individual HLC was not commercially available. In individual HLMs, the protein levels of CES1 and CES2 were apparently variable (4.7-and 3.5-fold, respectively), as reported in previous studies (Hosokawa et al., 1995; Xu et al., 2002) . To our knowledge, however, no study has investigated the variability in relative expression levels of CESs in the same individual HLMs. In the present study, it was demonstrated that the CES1 to CES2 level ratio substantially varied from 3.0 to 25 (Table 4) , and the correlation between the protein levels of CES1 and CES2 was negative (Fig. 6 ), indicating significant inter-individual variability and independence in their expression levels.
To further confirm the reliability of quantified protein levels, the correlations between the protein levels of CESs and hydrolysis activities for these substrates were This article has not been copyedited and formatted. The final version may differ from this version. (Sato et al., 2012) . The protein levels of CES1 correlated well with the hydrolysis rates of clopidogrel and oxybutynin, indicating that the quantified CES1 levels are reliable. Although three samples showed relatively high deviations from the regression curve (arrows in Fig. 7A and 7B ), this might have been due to genetic variants of CES1, which are known to potentially alter its hydrolysis activity and could not be distinguished by our quantification method (Sanghani et al., 2009 ). The protein levels of CES2 correlated strongly with the hydrolysis rates of irinotecan (1 7C ). It is known that both CES1 and CES2 are involved in the hydrolysis of irinotecan, but the hydrolysis at 1 μ M is overwhelmingly catalyzed by CES2 in HLMs (Slatter et al., 1997) . Thus, the strong correlation presented in Fig. 7C indicates the high reliability of quantified CES2 levels. At 100 μ M, where the contribution by CES1 is higher than that by CES2 (Slatter et al., 1997) , the correlation between the protein levels of CES2 and the hydrolysis rates of irinotecan were far less than those observed at 1 μ M (Fig. 7D ).
In conclusion, we developed a highly sensitive, accurate and robust method for the simultaneous quantification of CES1 and CES2 in human liver tissue fractions by combining tryptic digestion and LC-MS/MS analysis. The protein levels of CES1 and CES2 in HLMs were almost 10-fold higher than those in HLC, indicating that CESs are basically microsomal proteins. Furthermore, the protein levels of CES1 and CES2 in individual HLMs were found to be variable and independent of each other along with the much higher expression of CES1. Reliability of quantified protein levels was confirmed by significant correlations between the quantified protein levels and 
